We will be looking into the theme of ‘Optimization of therapy‘ for the conference and creating a programme split into sections to reflect this theme. The traditional, clinically-orientated expert reviews which make up the core of the IRPB will continue, as will sessions discussing new and existing pharmacological therapies, but these will be augmented by parallel sessions involving a variety of new themes and initiatives for 2015.
The conference will review recent exciting progress in genetic screening in Psychiatry, with special reference to how it can be used in the clinic today. Perhaps more importantly, we anticipate a lively debate on the ethics of genetic screening and appropriate patient counselling. In addition the conference will be reviewing adherence strategies and techniques to ensure optimal adherence and minimal relapse rates for patients, creating practical scenarios and workshops to help clinicians achieve long term remission for their patients.
To this end we welcome presentations and exhibitions from genetic screening (and associated) companies, and companies developing or promoting adherence-encouragement technologies.
Mais informação em http://www.irpb.info/